Skip to main content

About
Locations
Contact

English
Korean
Chinese, Simplified
Chinese, Traditional

Our Company
Our Culture
Board
Leadership
Awards

News & Resources
Solutions
Expertise
Careers

News & Resources
Solutions
Expertise
Careers
About
Locations
Contact

English
Korean
Chinese, Simplified
Chinese, Traditional

Our Company
Our Culture
Board
Leadership
Awards

English
Korean
Chinese, Simplified
Chinese, Traditional

News & Resources
Solutions
Expertise
Careers
About
Locations
Contact

BACK
Latest News
Latest Reports
Latest Webinars
Upcoming Events
Latest Case Studies
Latest Whitepapers
Latest FAQs
Covid Notices

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024
Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical Trial Landscape
Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

View All News

Metastatic Breast Cancer - Global Clinical Trial Landscape (2023)
Dyslipidaemia– Global Clinical trial landscape (2023)
Non-Small Cell Lung Cancer: Global Clinical Trial Landscape

View All Reports

Clinical trials in China: unlocking the potential of advanced therapies
Endpoints at BIO 2023: Forging new biotech ties with China
Endpoints at ASCO23: How to accelerate development in novel & advanced oncology therapies — from the starting line

View All Webinars

AES 2023 Annual Meeting
OCT East Asia 2023
MFDS/KSCD Annual Conference (Live)

View All Events

Rapid Subject Enrollment achieved for a Global COVID-19 vaccine phase 3 clinical trial for an international organization dedicated to accelerating vaccine R&D for global health
Phase I study helps company secure second indication for lead product with Healthy volunteer study in Australia
Biotechnology company looking for Oncology CRO services. Regulatory and recruitment expertise expedites clinical trial timelines for Oncology clinical study.

View All Case Studies

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy
Metastatic Breast Cancer: Navigating the Global Landscape of Challenges and Success in Clinical Trials
From Financial Challenges to Innovations: The Unfolding Story of the Biotech Sectors in 2023

View All Faqs

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)
Navigating The Biotech Landscape: Insights Into Clinical Trials, Funding Trends, Challenges, And Transformations Amidst Covid-19 And Beyond (2023)
The State of CAR-T Research in China

View All Whitepapers

BACK
Medical and Regulatory Consulting
Patient Recruitment and Site Selection
Early Phase Trials in Australia
Clinical Operations and Project Management
Site Management Organization (SMO)
Biometrics and Data Management
Virtual Clinical Trials
Real world data
Laboratory Services

BACK
Oncology CRO services
Pharmacometric Services
Drug Development Consulting
GMO Solutions
Liver Disease CRO services
Infectious diseases and Vaccines CRO services
Orphan and rare disease CRO services
Clinical and Regulatory Strategy

BACK

Working at Novotech

Life at Novotech

Career Development

Global Career Opportunities

China Career Opportunities

November 27, 2023 News

Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…

Hong Kong - Novotech, the leading Asia P

November 22, 2023 News

Novotech Publishes New Reports on Dyslipidaemia and Non-Small Cell Lung Cancer Global Clinical…

Boston, USA -

November 14, 2023 News

Navigating Global Innovation: Novotech's Insights on Accelerating China’s Biotech Development

China's Biotech Evolution: In recent years, the global biotech community has witnessed

View all news

November 21, 2023 Report

Metastatic Breast Cancer - Global Clinical Trial Landscape (2023)

Cutting-edge advancements in Metastatic Breast Cancer Clinical Trials Introduction: Clinical trials are pivotal in pushing forward the frontiers of metastatic breast cancer trea

October 24, 2023 Report

Dyslipidaemia– Global Clinical trial landscape (2023)

Dyslipidaemia, marked by abnormal blood lipids, significantly increases ischemic heart disease risk.

View all reports

September 19, 2023 Webinar

Clinical trials in China: unlocking the potential of advanced therapies

Arsalan Arif: Hi, everyone. I'm Arsalan Arif with Endpoints News.

June 21, 2023 Webinar

Endpoints at BIO 2023: Forging new biotech ties with China

John Caroll: Well, good afternoon, good morning, or wherever you may be in the world today

View all webinars

September 26, 2023 Case Study

Rapid Subject Enrollment achieved for a Global COVID-19 vaccine phase 3 clinical trial for an…

Background In the throes of the COVID-19 pandemic that enveloped the globe in 2021, there was an urgent and undeniable imperati

View all case studies

November 29, 2023 FAQ

From Breakthroughs to Challenges: A Comprehensive Exploration of Immune Checkpoint Inhibitors in Cancer Therapy

The landscape of cancer treatment has witnessed a revolutionary transformation with the advent of immune checkpoint inhibitors (ICIs), marking a paradigm shift in the approach to combating various

View all faqs

November 24, 2023 Whitepaper

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Explore the latest trends in immune checkpoint inhibitors clinical trials.

View all whitepapers

Covid-19 Notice important updates

Find content relevant to:

Liver Disease Oncology Hematology Cell and Gene Therapy Immunology Company News Disease Reports Webinars

December 1-5, 2023 Events

AES 2023 Annual Meeting

Orlando, Florida

December 5-6, 2023 Events

OCT East Asia 2023

Seoul, South Korea

View all events

Medical and Regulatory Consulting

Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.

Learn more
Patient Recruitment and Site Selection

Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites for your study.

Learn more
Early Phase Trials in Australia

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

Learn more
Clinical Operations and Project Management

Novotech’s streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.

Learn more
Site Management Organization (SMO)

Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.

Learn more
Biometrics and Data Management

Delivering accurate, high-quality and timely biostatistics in clinical trials services, including statistical planning, analysis and reporting.

Learn more
Virtual Clinical Trials

How virtual clinical trials can offer patient retention and cost benefits compared to traditional trials.

Learn more
Real world data

Accelerating patient recruitment and drug development with real world data (RWD)

Learn more
Laboratory Services

Our bioanalytical services assist our customers in every stage of their molecule development.

Learn more

Oncology CRO services

The landscape of Oncology in Asia-Pacific Biotechnology companies are facing increased challenges around participant recruitment and rete

Learn more
Pharmacometric Services

Our team can assist in all clinical study phases and in study designs ranging from first in human, single ascending dose, multiple ascending dose, drug-drug interaction, bioavailability/bioequivalence, food effect and special population studies.

Learn more
Drug Development Consulting

Novotech Drug Development Consulting is a full-service global product development and strategic regulatory group, providing comprehensive “lab to launch” program development services.

Learn more
GMO Solutions

Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited b

Learn more
Liver Disease CRO services

The landscape of Liver diseases in Asia-Pacific Biotechnology companies consider locations in the Asia-Pacific region, s

Learn more
Infectious diseases and Vaccines CRO services

Providing Infectious diseases services and Vaccines CRO services Many biotechnology companies look at the Asia-Pacific region for their t

Learn more
Orphan and rare disease CRO services

Landscape of Rare and Orphan diseases in Asia-Pacific There may be as many as 8,000 rare diseases, affecting between 6% and 8% of the wor

Learn more
Clinical and Regulatory Strategy

Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and

Learn more

People Culture

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Working at Novotech

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house Novotech Drug Development Consulting team.

Life at Novotech

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

Career Development

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

Our MISSION is to create career development opportunity for everyone.

Global Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

China Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

November 25, 2022

Home / Reports

Glaucoma Asia Pacific – Clinical trial landscape

Owing to a large and ageing population base, Asia accounts for more than 60% of the estimated global cases of glaucoma.

Other relevant content

June 15, 2022 Report

Acute pancreatitis – Asia pacific – clinical Trial landscape

September 1, 2022 Report

Non-alcoholic steatohepatitis (NASH) Asia Pacific – Clinical trial landscape

November 18, 2022 Report

Diabetic Retinopathy Asia Pacific – Clinical Trial Landscape

August 21, 2019 Case Study

Providing Gastrointestinal CRO services and Metabolic diseases CRO services. Integrated approach…

Talk to an expert team member

Receive a timely response to an enquiry about a service, process or technical questions.
Enter your details and the right person at Novotech will get in touch with you soon.

First Name

Last Name

Company Name

Company Email

Job Title

Phone

How can we help?

I agree to the terms of service.

By ticking this box, you consent to us storing and processing your personal data to provide you this content and future content that may be of interest. To withdraw consent or unsubscribe at any time contact communications@novotech-cro.com.

News & Resources
Solutions
Expertise
Careers
About
Contact

© Novotech 2023 - All rights reserved. Privacy Whistle-blower policy Disclaimer NHH Slavery Statement NHH Recruitment Scams - Website Alert Change of Banking Details Scam